KEYTRUDA® (pembrolizumab) - Official Site
KEYTRUDA is a prescription medicine used to treat a kind of lung cancer called non–small cell lung cancer (NSCLC). KEYTRUDA may be used with the chemotherapy medicines pemetrexed and a platinum as your first treatment when your lung cancer has spread (advanced NSCLC) is a type called “nonsquamous”.
Side Effects of KEYTRUDA® (pembrolizumab)
Common side effects of KEYTRUDA when used alone include: feeling tired, pain, including pain in muscles, rash, diarrhea, fever, cough, decreased appetite, itching, shortness of breath, constipation, bones or joints and stomach-area (abdominal) pain, nausea, and low levels of thyroid hormone.
Infusion Information and Resources for ... - KEYTRUDA
When starting a new medication, it can be reassuring to know what to expect. Explore this page to help you or your care partner feel more confident in starting treatment with KEYTRUDA, including: What to expect on your first infusion. What to know about your treatment schedule. Side effects and when to speak up.
COST INFO & FINANCIAL HELP - KEYTRUDA
Cost information for patients. Financial assistance. Figuring out what you might pay out of pocket for a prescription medicine can be confusing. What you pay will depend on many factors, including your insurance situation and if there are financial support options available to you.
KEYTRUDA® (pembrolizumab) for Non–Small Cell Lung Cancer
FDA-Approved Indications. KEYTRUDA is a prescription medicine used to treat a kind of lung cancer called non–small cell lung cancer (NSCLC). KEYTRUDA may be used with the chemotherapy medicines pemetrexed and a platinum as your first treatment when your lung cancer has spread (advanced NSCLC) and is a type called “nonsquamous” and your ...
Advanced Cervical Cancer - KEYTRUDA® (pembrolizumab) - Patients
Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please read the accompanying Medication Guide for KEYTRUDA and discuss it with your doctor. The physician also is available. Learn about a treatment option that may help people with certain types of advanced cervical cancer.
Non-Muscle Invasive Bladder Cancer (NMIBC) - KEYTRUDA
Learn about a treatment option that may help certain patients with high-risk non-muscle invasive bladder cancer (NMIBC).
Triple-Negative Breast Cancer (TNBC) - KEYTRUDA
KEYTRUDA is an immunotherapy that works with your immune system to help treat certain cancers. If you have early-stage breast cancer and are at high risk of your cancer returning, KEYTRUDA may be used with chemotherapy before surgery, then alone after surgery.
FAQs About KEYTRUDA® (pembrolizumab)
Please read the accompanying Medication Guide for KEYTRUDA and discuss it with your doctor. The physician Prescribing Information also is available. Find answers to frequently asked questions about KEYTRUDA® (pembrolizumab) including how does KEYTRUDA work, PD-L1 testing information, and more.
Urothelial Bladder Cancers | KEYTRUDA® (pembrolizumab)
KEYTRUDA used alone and KEYTRUDA with enfortumab vedotin have both been studied in clinical trials in patients with advanced urothelial bladder cancer (UC). See if KEYTRUDA is right for you. Results from clinical trials.